Why the study?
Does glucose-insulin-potassium infusion reduce mortality and improve left ventricular mechanical performance in patients with acute myocardial infarction?
Does glucose-insulin-potassium infusion reduce mortality and improve left ventricular mechanical performance in patients with acute myocardial infarction?
Glucose-insulin-potassium infusion may offer beneficial effects such as reduced mortality and improved left ventricular performance in acute myocardial infarction, though further studies are needed to confirm efficacy.
May support GIK consideration in AMI but should not change practice; leaves open confirmation by randomized trials.
A solution of 300 gm of glucose, 50 units of regular insulin, and 80 mEq of potassium chloride in 1,000 ml of sterile water infused at a rate of 1.5 ml/kg of body weight per hour can alter the availability of glucose and free fatty acids to the myocardium. Clinical studies of patients receiving this infusion less than 15 hours after the onset of symptoms of acute myocardial infarction suggest a reduction in mortality, an improvement in left ventricular mechanical performance, and a reduction in cardiac irritability as beneficial effects. Swan-Ganz catheterization for hemodynamic, electrophysiologic, and metabolic monitoring is recommended. Diabetics who require insulin and patients with impaired renal function are not candidates for the infusion. Further clinical studies are required before conclusions can be reached regarding the efficacy of glucose-insulin-potassium infusion in attempts to salvage damaged myocardium.
No takes yet. Share an insight, caveat, or question.
Rackley et al. (1979) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: